John Lettieri

2.3k total citations
77 papers, 1.9k citations indexed

About

John Lettieri is a scholar working on Pharmacology, Surgery and Oncology. According to data from OpenAlex, John Lettieri has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 17 papers in Surgery and 16 papers in Oncology. Recurrent topics in John Lettieri's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Lipoproteins and Cardiovascular Health (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). John Lettieri is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Lipoproteins and Cardiovascular Health (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). John Lettieri collaborates with scholars based in United States, Germany and France. John Lettieri's co-authors include Allen H. Heller, G.J. Krol, R. Wayne Frost, H L Fung, Roger Echols, Martin Radtke, Lee Kaiser, P. R. Sundaresan, Frank Cihon and Chetan Lathia and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

John Lettieri

76 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Lettieri United States 25 790 381 377 373 270 77 1.9k
Hideo Hakusui Japan 19 472 0.6× 574 1.5× 152 0.4× 581 1.6× 131 0.5× 88 1.6k
Murray P. Ducharme Canada 24 437 0.6× 636 1.7× 301 0.8× 710 1.9× 93 0.3× 79 3.0k
Wen Chyi Shyu United States 23 501 0.6× 270 0.7× 228 0.6× 408 1.1× 164 0.6× 78 1.6k
Guy Montay France 25 679 0.9× 658 1.7× 296 0.8× 442 1.2× 235 0.9× 60 2.0k
Leo Stolk Netherlands 23 623 0.8× 249 0.7× 202 0.5× 468 1.3× 47 0.2× 68 2.4k
Helen Winter United States 25 308 0.4× 371 1.0× 360 1.0× 329 0.9× 43 0.2× 69 1.9k
Craig K. Svensson United States 25 755 1.0× 234 0.6× 254 0.7× 478 1.3× 29 0.1× 74 2.4k
Christopher Banfield United States 30 426 0.5× 515 1.4× 301 0.8× 328 0.9× 110 0.4× 88 2.8k
Marion L. Williams United States 19 204 0.3× 177 0.5× 192 0.5× 678 1.8× 589 2.2× 28 2.0k
Aaron Dane United Kingdom 26 396 0.5× 363 1.0× 407 1.1× 182 0.5× 416 1.5× 52 1.9k

Countries citing papers authored by John Lettieri

Since Specialization
Citations

This map shows the geographic impact of John Lettieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lettieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lettieri more than expected).

Fields of papers citing papers by John Lettieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lettieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lettieri. The network helps show where John Lettieri may publish in the future.

Co-authorship network of co-authors of John Lettieri

This figure shows the co-authorship network connecting the top 25 collaborators of John Lettieri. A scholar is included among the top collaborators of John Lettieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lettieri. John Lettieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerisch, Michael, Dieter Lang, Martin Radtke, et al.. (2017). Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects. Cancer Chemotherapy and Pharmacology. 81(1). 195–206. 34 indexed citations
2.
Hellmann, Matthew D., Isrid Sturm, John Lettieri, et al.. (2015). Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancers. Clinical Lung Cancer. 16(6). 514–522. 12 indexed citations
3.
Cleton, Adriaan, et al.. (2015). P-261 Pharmacokinetics of regorafenib in the phase 3 CONCUR and CORRECT trials in patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 26. iv76–iv76. 1 indexed citations
4.
Lettieri, John, et al.. (2011). Assessment of the Effects of Renal Impairment on the Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat After a Single Intravenous Dose. The Journal of Clinical Pharmacology. 52(8). 1240–1247. 3 indexed citations
5.
Goldman, Mitchel P., Thomas L. Roberts, Greg R. Skover, John Lettieri, & Richard Fitzpatrick. (2002). Optimizing wound healing in the face after laser abrasion. Journal of the American Academy of Dermatology. 46(3). 399–407. 16 indexed citations
6.
Isaacsohn, Jonathan L., et al.. (2001). Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults. European Journal of Clinical Pharmacology. 56(12). 897–903. 5 indexed citations
7.
Lettieri, John, et al.. (2001). Effect of Food on the Pharmacokinetics of a Single Oral Dose of Moxifloxacin 400mg in Healthy Male Volunteers. Clinical Pharmacokinetics. 40(Supplement 1). 19–25. 34 indexed citations
8.
9.
Mazzu, Arthur, John Lettieri, Lee Kaiser, William S. Mullican, & Allen H. Heller. (1998). Influence of Age on the Safety, Tolerability, and Pharmacokinetics of the Novel HMG‐CoA Reductase Inhibitor Cerivastatin in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 38(8). 715–719. 4 indexed citations
10.
Lettieri, John & Bradley Dain. (1998). Effects of Beano on the tolerability and pharmacodynamics of acarbose. Clinical Therapeutics. 20(3). 497–504. 12 indexed citations
11.
Rubio, Thomas, Michael V. Miles, John Lettieri, et al.. (1997). Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. The Pediatric Infectious Disease Journal. 16(1). 112–117. 36 indexed citations
12.
Israel, Debra S., Jennifer L. Stotka, William Rock, et al.. (1996). Effect of Ciprofloxacin on the Pharmacokinetics and Pharmacodynamics of Warfarin. Clinical Infectious Diseases. 22(2). 251–256. 41 indexed citations
13.
Sramek, John J., Allen H. Heller, P. R. Sundaresan, et al.. (1994). Safety and Tolerance of Intravenous Nimodipine. Annals of Pharmacotherapy. 28(10). 1143–1148. 4 indexed citations
14.
Lettieri, John, et al.. (1994). Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily. Journal of Antimicrobial Chemotherapy. 33(4). 795–801. 32 indexed citations
15.
Krol, G.J., et al.. (1993). LC separation and induced fluorometric detection of rivastatin in blood plasma. Journal of Pharmaceutical and Biomedical Analysis. 11(11-12). 1269–1275. 24 indexed citations
16.
Lettieri, John, et al.. (1991). Lidocaine Diffusion in Five Tissue Expanders: An In Vitro and In Vivo Study. Annals of Plastic Surgery. 27(4). 312–315. 2 indexed citations
17.
Prince, Randall A., Ed Casabar, Colin G. Adair, et al.. (1989). Effect of Quinolone Antimicrobials on Theophylline Pharmacokinetics. The Journal of Clinical Pharmacology. 29(7). 650–654. 23 indexed citations
18.
Frost, R. Wayne, et al.. (1989). The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin. Clinical Pharmacology & Therapeutics. 45(6). 608–616. 26 indexed citations
19.
Stuart, Janine, John G. Kenney, John Lettieri, William D. Spotnitz, & Joseph W. Baker. (1988). Application of Single-Donor Fibrin Glue to Burns. Journal of Burn Care & Rehabilitation. 9(6). 619–622. 29 indexed citations
20.
Lettieri, John, et al.. (1983). Effects of competitive red blood cell binding and reduced hematocrit on the blood and plasma levels of [14C]Indapamide in the rat.. Journal of Pharmacology and Experimental Therapeutics. 224(2). 269–272. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Hakusui Breakdown of academic impact, for papers by Murray P. Ducharme Breakdown of academic impact, for papers by Wen Chyi Shyu Breakdown of academic impact, for papers by Guy Montay Breakdown of academic impact, for papers by Leo Stolk Breakdown of academic impact, for papers by Helen Winter Breakdown of academic impact, for papers by Craig K. Svensson Breakdown of academic impact, for papers by Christopher Banfield Breakdown of academic impact, for papers by Marion L. Williams Breakdown of academic impact, for papers by Aaron Dane
Rankless by CCL
2026